Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2023-10-17 2:57:41 pm | Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio | GlobeNewsWire |
| 2023-10-06 2:9:0 pm | Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio | GlobeNewswire |
| 2023-10-04 5:30:0 am | New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris Therapeutics | GlobeNewswire |
| 2023-09-12 12:16:22 pm | We're Keeping An Eye On Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Rate | Simply Wall St. |
Please consider a small donation if you think this website provides you with relevant information